Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15117962rdf:typepubmed:Citationlld:pubmed
pubmed-article:15117962lifeskim:mentionsumls-concept:C1333547lld:lifeskim
pubmed-article:15117962lifeskim:mentionsumls-concept:C0026845lld:lifeskim
pubmed-article:15117962lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:15117962lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:15117962lifeskim:mentionsumls-concept:C0021701lld:lifeskim
pubmed-article:15117962lifeskim:mentionsumls-concept:C1414613lld:lifeskim
pubmed-article:15117962pubmed:issue27lld:pubmed
pubmed-article:15117962pubmed:dateCreated2004-6-28lld:pubmed
pubmed-article:15117962pubmed:abstractTextFHL1, FHL2, and FHL3 are members of the four and one-half LIM domain protein subclass that are expressed in striated muscles. Here we show that FHL2 and FHL3 are novel alpha(7)beta(1) integrin-interacting proteins. They bind both the alpha- and the beta-subunit as well as different splice isoforms. The minimal binding sites for FHL2 and FHL3 on beta(1A)-chain overlap, whereas on alpha(7A) and alpha(7B) subunits they are situated adjacent. Determining the binding sites for integrins on FHL2 or FHL3 revealed that the suprastructure of the whole molecule is important for these associations, rather than any single LIM domain. Immunofluorescence studies with cells expressing full-length FHL proteins or their deletion mutants showed that FHL2 and FHL3 but not FHL1 colocalize with integrins at cell adhesion sites. Further, their recruitment to the membrane results from binding to either the alpha- or the beta-chain of the integrin receptor. The association of FHL2 or FHL3 with integrin receptors neither influences attachment of cells to different substrates nor changes their migration capacity. However, in cardiac and skeletal muscles, FHL2 and FHL3, respectively, are colocalized with alpha(7)beta(1) integrin receptor at the periphery of Z-discs, suggesting a role in mechanical stabilization of muscle cells.lld:pubmed
pubmed-article:15117962pubmed:languageenglld:pubmed
pubmed-article:15117962pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:citationSubsetIMlld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15117962pubmed:statusMEDLINElld:pubmed
pubmed-article:15117962pubmed:monthJullld:pubmed
pubmed-article:15117962pubmed:issn0021-9258lld:pubmed
pubmed-article:15117962pubmed:authorpubmed-author:von der...lld:pubmed
pubmed-article:15117962pubmed:authorpubmed-author:von der...lld:pubmed
pubmed-article:15117962pubmed:authorpubmed-author:WendlerOlafOlld:pubmed
pubmed-article:15117962pubmed:authorpubmed-author:SmythNeilNlld:pubmed
pubmed-article:15117962pubmed:authorpubmed-author:MüllerJudith...lld:pubmed
pubmed-article:15117962pubmed:authorpubmed-author:SchüleRolandRlld:pubmed
pubmed-article:15117962pubmed:authorpubmed-author:WixlerViktorVlld:pubmed
pubmed-article:15117962pubmed:authorpubmed-author:JanetzkyStefa...lld:pubmed
pubmed-article:15117962pubmed:authorpubmed-author:SamsonThomasTlld:pubmed
pubmed-article:15117962pubmed:issnTypePrintlld:pubmed
pubmed-article:15117962pubmed:day2lld:pubmed
pubmed-article:15117962pubmed:volume279lld:pubmed
pubmed-article:15117962pubmed:ownerNLMlld:pubmed
pubmed-article:15117962pubmed:authorsCompleteYlld:pubmed
pubmed-article:15117962pubmed:pagination28641-52lld:pubmed
pubmed-article:15117962pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:meshHeadingpubmed-meshheading:15117962...lld:pubmed
pubmed-article:15117962pubmed:year2004lld:pubmed
pubmed-article:15117962pubmed:articleTitleThe LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor.lld:pubmed
pubmed-article:15117962pubmed:affiliationLehrstuhl für Experimentelle Medizin I, Nikolaus-Fiebiger Zentrum für Molekulare Medizin, Friedrich-Alexander Universität Erlangen/Nürnberg, Glückstrasse 6, 91054 Erlangen, Germany.lld:pubmed
pubmed-article:15117962pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15117962pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed